The stock of CVS Health Corp (CVS) has gone up by 6.10% for the week, with a 12.36% rise in the past month and a 2.71% rise in the past quarter. The volatility ratio for the week is 0.73%, and the volatility levels for the past 30 days are 1.52% for CVS. The simple moving average for the past 20 days is 6.41% for CVS’s stock, with a 12.75% simple moving average for the past 200 days.
Is It Worth Investing in CVS Health Corp (NYSE: CVS) Right Now?
CVS Health Corp (NYSE: CVS) has a higher price-to-earnings ratio of 16.11x compared to its average ratio, The 36-month beta value for CVS is at 0.56. Analysts have varying views on the stock, with 13 analysts rating it as a “buy,” 8 rating it as “overweight,” 7 as “hold,” and 0 as “sell.”
The public float for CVS is 1.26B, and currently, shorts hold a 1.22% of that float. The average trading volume for CVS on June 16, 2025 was 9.99M shares.
CVS) stock’s latest price update
CVS Health Corp (NYSE: CVS)’s stock price has plunge by 1.67relation to previous closing price of 66.35. Nevertheless, the company has seen a 6.10% surge in its stock price over the last five trading sessions. zacks.com reported 2025-06-12 that Here are four discounted PEG stocks that qualify our screening criteria and could be good picks. These are FLEX, CVS, URBN and EXEL.
Analysts’ Opinion of CVS
Many brokerage firms have already submitted their reports for CVS stocks, with Leerink Partners repeating the rating for CVS by listing it as a “Outperform.” The predicted price for CVS in the upcoming period, according to Leerink Partners is $75 based on the research report published on February 13, 2025 of the current year 2025.
CVS Trading at 3.63% from the 50-Day Moving Average
After a stumble in the market that brought CVS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -6.96% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CVS starting from SANSONE GUY P, who purchase 1,570 shares at the price of $63.70 back on Jun 05 ’25. After this action, SANSONE GUY P now owns 12,007 shares of CVS Health Corp, valued at $100,009 using the latest closing price.
ROBBINS LARRY, the Director of CVS Health Corp, sale 2,276,068 shares at $67.86 during a trade that took place back on May 02 ’25, which means that ROBBINS LARRY is holding 9,670,731 shares at $154,444,758 based on the most recent closing price.
Stock Fundamentals for CVS
Current profitability levels for the company are sitting at:
- 0.03 for the present operating margin
- 0.14 for the gross margin
The net margin for CVS Health Corp stands at 0.01. The total capital return value is set at 0.06. Equity return is now at value 7.00, with 2.09 for asset returns.
Based on CVS Health Corp (CVS), the company’s capital structure generated 0.51 points at debt to capital in total, while cash flow to debt ratio is standing at 0.11. The debt to equity ratio resting at 1.06. The interest coverage ratio of the stock is 3.18.
Currently, EBITDA for the company is 13.68 billion with net debt to EBITDA at 4.8. When we switch over and look at the enterprise to sales, we see a ratio of 0.41. The receivables turnover for the company is 9.56for trailing twelve months and the total asset turnover is 1.48. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.82.
Conclusion
In conclusion, CVS Health Corp (CVS) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
